NEALS is pleased to announce a full day in-person training session Friday, April 1st, 2022 in Boston, Massachusetts for Investigators (MD) interested in developing and conducting multi-center ALS clinical trials as Principal Investigators.
The Neurological Clinical Research Institute at Massachusetts General Hospital is seeking individuals to participate in a Longitudinal Assessment of the Gut Microbiome in People with ALS research study currently enrolling under the direction of Dr. James Berry.
The Emory ALS Center is looking for adults who are 18 years and older who are at risk for getting diagnosed with C9 ALS in the future.
The Subcommittee on Health of the Committee on Energy and Commerce will hold a hybrid hearing that includes both in-person and remote attendance on Thursday, July 29, 2021, at 11:00 a.m. ET.
Amylyx will present the trial design of its Phase 3 ALS study (A35-004 PHOENIX) of AMX0035 at the European Network to Cure ALS (ENCALS) Meeting 2021.
The ALS Team at the Healey Center at Mass General Hospital is committed to an ongoing dialogue about the HEALEY ALS Platform Trial with the entire ALS patient community.
Please join us on Tuesday, September 29th at 5:00 pm EST for an update on the HEALEY ALS Platform Trial and remarks from Kuldip Dave of the ALS Association.
Nominations are now being accepted for the 2020 Virtual Clinical Research Learning Institute!
As the first ever platform trial for amyotrophic lateral sclerosis (ALS), the HEALEY ALS Platform Trial is testing three proposed drug regimens and will add two more over the next several months.
NEALS is pleased to announce a half-day training session for investigators interested in participating in ALS research as a Site Investigator in a multi-center clinical trial.
